HRL

Hormel Foods Corp. 10-Q Summary: Quarter Ended July 26, 2026

Business Context and Reporting Period

This summary covers Hormel Foods Corporation's (HRL) Form 10-Q for the quarterly period ended July 26, 2026, and the nine months ended on that date. Hormel is a global manufacturer and marketer of branded food products operating through three segments: Retail, Foodservice, and International. The company reported a significant decline in GAAP earnings due to discrete non-recurring items, including divestitures, impairments, and litigation settlements.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Net sales decreased 2.4% in Q3 2026 compared to Q3 2025, driven by declines in the Retail and International segments, partially offset by growth in Foodservice. Organic net sales declined 1.7% in Q3.
• Profitability: GAAP Net Earnings dropped 67.6% year-over-year in Q3. This decline was primarily driven by a $155 million pre-tax impact from nonrecurring items, including a $56.1 million loss on the Brazil divestiture, a $48.2 million impairment charge on an Indonesian investment, and a $37.5 million litigation settlement.
• Segment Performance:
  • Retail: Sales and profit declined due to lower volume in commodity turkey and private label snack nuts, offset by growth in premium prepared proteins.
  • Foodservice: Sales and profit increased, driven by premium prepared proteins and customized solutions.
  • International: Reported a segment loss of $29.2M in Q3, significantly impacted by the $48.2M impairment charge. Adjusted segment profit was flat compared to the prior year.
• Cash Flow: Operating cash flow for the first nine months increased 47% to $769 million, reflecting improved inventory management and working capital performance.

Guidance, Outlook, and Risks

• Outlook: Management expects net sales growth for fiscal 2026, assuming broad category growth and market-based pricing. Capital expenditures for fiscal 2026 are estimated between $260 million and $290 million.
• Dividends: The Board authorized a quarterly dividend of $0.2925 per share for Q3 2026, a 1% increase from the prior year.
• Risks and Contingencies:
  • Divestitures: The company finalized the sale of its Brazil operations (Ceratti brand) and its whole-bird turkey business. The Brazil sale resulted in a significant valuation loss.
  • Impairments: A $48.2 million non-cash impairment was recorded for the Garudafood investment in Indonesia due to a decline in market price.
  • Litigation: A $37.5 million settlement was recorded regarding the Turkey Antitrust Litigation. The company continues to defend against remaining claims.
  • Restructuring: The company is executing a corporate restructuring plan with estimated total charges of $22.0 million, primarily for severance and pension benefits.

Investor Verification Checklist

• Non-GAAP Adjustments: Verify the reconciliation of GAAP to Adjusted EPS ($0.37 for Q3), which excludes $155 million in pre-tax nonrecurring costs. Assess whether these items are truly non-recurring or indicative of structural issues.
• Divestiture Proceeds: Confirm the final cash proceeds from the Brazil and whole-bird turkey sales and the impact on future working capital.
• Impairment Sustainability: Review the valuation methodology for the Garudafood investment to determine if further impairments are likely given market conditions in Indonesia.
• Debt Maturity: Note the reclassification of $500 million of senior notes to current maturities due in March 2027 and assess refinancing plans.
• Organic Volume Trends: Monitor the continued decline in organic volume (-7.1% in Q3), particularly in the commodity turkey portfolio, to gauge demand recovery.